As the number of smokers declines, a worrying trend has emerged: non-smokers are increasingly developing lung cancer , particularly among young women. This troubling statistic has a clear explanation, yet combating it remains a challenge.
While smoking rates have significantly declined in recent years, a paradoxical trend is raising alarms among experts: more non-smokers are developing lung cancer . Historically, this disease was largely associated with cigarette use, but lung cancer is evolving .
“When we see people aged 30 or 35 diagnosed with lung cancer, they generally have never smoked,” warns Andreas Wicki, an oncologist at the University Hospital of Zurich, in an interview with the BBC. This trend challenges existing assumptions. According to the International Agency for Research on Cancer (IARC), between 10% and 20% of lung cancer cases worldwide now concern non-smokers . This is a rising figure!
Women More Susceptible to Lung Cancer
Among the new at-risk profiles are women, often young , who have no history of smoking. The most common type of tumor observed in them is adenocarcinoma , a form of cancer that develops in lung mucus. This particular type of tumor is insidious. It progresses slowly and often without noticeable symptoms, which can delay diagnosis . As a result, the disease is frequently detected at an advanced stage, diminishing treatment options.
The increase in lung cancer among non-smokers can be attributed to several factors. The first being air pollution , particularly fine particulate matter. These microparticles, which stem mainly from road traffic and industrial combustion, adversely affect lung cells. “Our study suggests that fine particles do not directly mutate DNA but awaken dormant mutant cells in the lungs,” explains William Hill, a researcher at the Francis Crick Institute in London.
© Vera Agency/Shutterstock
Pollution and Genetics: Two Key Causes
Another contributing factor is genetics . In some patients, the mutations responsible for cancer are present in the body from birth. The EGFR gene , in particular, has been identified in numerous non-smoking Asian women diagnosed with lung cancer. This discovery has led to the development of targeted treatments, significantly improving survival rates.
However, despite these advancements, screening remains largely focused on smokers. Many specialists consider this approach too restrictive. The risk exists that we may overlook warning signs among non-smokers, a group increasingly affected by the disease. Experts are thus calling for a revision of public health policies. It has become urgent to expand screening criteria to account for the evolving profile of individuals impacted by lung cancer. The condition no longer merely results from tobacco consumption; it’s time to adapt medical and political responses to this new reality.
In conclusion, the rising incidence of lung cancer among non-smokers, especially young women, highlights the need for more inclusive health policies and screening practices. With preventive measures and research aimed at understanding the complex interplay of genetic factors and environmental influences, there is hope for improving outcomes for affected individuals. Acknowledging that lung cancer is not solely a smoker’s disease can lead to more effective interventions and ultimately save lives.